An Approach to Minimize Tumour Proliferation by Reducing the Formation of Components for Cell Membrane

Isoprenoids are natural compounds essential for a great number of cellular functions. One of them is farnesol (FOH), which can reduce cell proliferation, but its low solubility in aqueous solvents limits its possible clinical use as a pharmacological tool. One alternative is the use of cyclodextrins...

Full description

Bibliographic Details
Main Authors: Inmaculada de Dios-Pérez, Álvaro González-Garcinuño, Eva María Martín del Valle
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/27/9/2735
_version_ 1797503774538858496
author Inmaculada de Dios-Pérez
Álvaro González-Garcinuño
Eva María Martín del Valle
author_facet Inmaculada de Dios-Pérez
Álvaro González-Garcinuño
Eva María Martín del Valle
author_sort Inmaculada de Dios-Pérez
collection DOAJ
description Isoprenoids are natural compounds essential for a great number of cellular functions. One of them is farnesol (FOH), which can reduce cell proliferation, but its low solubility in aqueous solvents limits its possible clinical use as a pharmacological tool. One alternative is the use of cyclodextrins (CDs) which house hydrophobic molecules forming inclusion complexes. To assess FOH potential application in anticancer treatments, Sulfobutylated β-cyclodextrin Sodium Salt (SBE-β-CD) was selected, due to it has high solubility, approbation by the FDA, and numerous studies that ensure its safety to be administered parenterally or orally without nephrotoxicity associated. The therapeutic action of farnesol and complex were studied in different carcinoma cells, compared with a normal cell line. Farnesol showed selectivity, affecting the viability of colon and liver cancer cells more than in breast cancer cells and fibroblasts. All cells suffered apoptosis after being treated with 150 μM of free FOH, but the complex reduced their cell viability between 50 and 75%. Similar results were obtained for both types of isomers, and the addition of phosphatidylcholine reverses this effect. Finally, cell cycle analysis corroborates the action of FOH as inducer of a G0/G1 phase; when the cells were treated using the complex form, this viability was reduced, reaching 50% in the case of colon and liver, 60% in fibroblasts, and only 75% in breast cancer.
first_indexed 2024-03-10T03:55:09Z
format Article
id doaj.art-e7057e3e9e34436a8498cb0a5f3bb8b0
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-10T03:55:09Z
publishDate 2022-04-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-e7057e3e9e34436a8498cb0a5f3bb8b02023-11-23T08:48:51ZengMDPI AGMolecules1420-30492022-04-01279273510.3390/molecules27092735An Approach to Minimize Tumour Proliferation by Reducing the Formation of Components for Cell MembraneInmaculada de Dios-Pérez0Álvaro González-Garcinuño1Eva María Martín del Valle2Department of Chemical Engineering, University of Salamanca, 37008 Salamanca, SpainDepartment of Chemical Engineering, University of Salamanca, 37008 Salamanca, SpainDepartment of Chemical Engineering, University of Salamanca, 37008 Salamanca, SpainIsoprenoids are natural compounds essential for a great number of cellular functions. One of them is farnesol (FOH), which can reduce cell proliferation, but its low solubility in aqueous solvents limits its possible clinical use as a pharmacological tool. One alternative is the use of cyclodextrins (CDs) which house hydrophobic molecules forming inclusion complexes. To assess FOH potential application in anticancer treatments, Sulfobutylated β-cyclodextrin Sodium Salt (SBE-β-CD) was selected, due to it has high solubility, approbation by the FDA, and numerous studies that ensure its safety to be administered parenterally or orally without nephrotoxicity associated. The therapeutic action of farnesol and complex were studied in different carcinoma cells, compared with a normal cell line. Farnesol showed selectivity, affecting the viability of colon and liver cancer cells more than in breast cancer cells and fibroblasts. All cells suffered apoptosis after being treated with 150 μM of free FOH, but the complex reduced their cell viability between 50 and 75%. Similar results were obtained for both types of isomers, and the addition of phosphatidylcholine reverses this effect. Finally, cell cycle analysis corroborates the action of FOH as inducer of a G0/G1 phase; when the cells were treated using the complex form, this viability was reduced, reaching 50% in the case of colon and liver, 60% in fibroblasts, and only 75% in breast cancer.https://www.mdpi.com/1420-3049/27/9/2735farnesolphosphatidylcholinephosphocholine cytidylyltransferasecyclodextrinssulfobutylated β-cyclodextrin
spellingShingle Inmaculada de Dios-Pérez
Álvaro González-Garcinuño
Eva María Martín del Valle
An Approach to Minimize Tumour Proliferation by Reducing the Formation of Components for Cell Membrane
Molecules
farnesol
phosphatidylcholine
phosphocholine cytidylyltransferase
cyclodextrins
sulfobutylated β-cyclodextrin
title An Approach to Minimize Tumour Proliferation by Reducing the Formation of Components for Cell Membrane
title_full An Approach to Minimize Tumour Proliferation by Reducing the Formation of Components for Cell Membrane
title_fullStr An Approach to Minimize Tumour Proliferation by Reducing the Formation of Components for Cell Membrane
title_full_unstemmed An Approach to Minimize Tumour Proliferation by Reducing the Formation of Components for Cell Membrane
title_short An Approach to Minimize Tumour Proliferation by Reducing the Formation of Components for Cell Membrane
title_sort approach to minimize tumour proliferation by reducing the formation of components for cell membrane
topic farnesol
phosphatidylcholine
phosphocholine cytidylyltransferase
cyclodextrins
sulfobutylated β-cyclodextrin
url https://www.mdpi.com/1420-3049/27/9/2735
work_keys_str_mv AT inmaculadadediosperez anapproachtominimizetumourproliferationbyreducingtheformationofcomponentsforcellmembrane
AT alvarogonzalezgarcinuno anapproachtominimizetumourproliferationbyreducingtheformationofcomponentsforcellmembrane
AT evamariamartindelvalle anapproachtominimizetumourproliferationbyreducingtheformationofcomponentsforcellmembrane
AT inmaculadadediosperez approachtominimizetumourproliferationbyreducingtheformationofcomponentsforcellmembrane
AT alvarogonzalezgarcinuno approachtominimizetumourproliferationbyreducingtheformationofcomponentsforcellmembrane
AT evamariamartindelvalle approachtominimizetumourproliferationbyreducingtheformationofcomponentsforcellmembrane